SEENERGIE
Unleash Human Potential
DSIP
Delta Sleep-Inducing Peptide influences neuromodulation to facilitate better sleep, elevate mood, and improves stress management.
Active ingredient:
n/a
Molecular formula:
C35H48N10O15
Molecular weight:
848.8 g/mol
Intake:
Injection
DSIP
Active ingredient:
n/a
Molecular formula:
C35H48N10O15
Molecular weight:
848.8 g/mol
Intake:
Injection
What is
DSIP
DSIP, short for Delta Sleep-Inducing Peptide, is a somnogeneric peptide that influences neuromodulation. It is typically present in the brain and rapidly crosses the blood-brain barrier. Research indicates that DSIP and its analogs are categorized as peptide neuromodulators.
Studies have also revealed that DSIP possesses a stress-protective effect, aiding in the reduction of stress-related metabolic disorders in both humans and animals. It is believed that Delta Sleep-Inducing Peptide operates by modulating the activity of GABAergic, glutamatergic, and other neuronal systems.
Benefits
- Elevates mood
- Mitigates chronic pain
- Enhances energy levels
- Facilitates improved sleep
- Alleviates emotional and psychological responses to stress
Protocols
- Content and Potency
Provided as a 5mg lyophilized vial
- Suggested Dosage
- Initiation: DSIP therapy is initiated to support sleep regulation, reduce sleep disturbances, and enhance overall sleep quality by modulating sleep-inducing mechanisms.
- Initial Dose: Begin with 250 mcg (0.1 ml or 10 units) subcutaneously once daily (hs – 2-12 hours before bedtime) for the first two weeks to assess tolerance and minimize potential side effects.
- Titration: If well tolerated, increase the dose to 500 mcg (0.2 ml or 20 units) subcutaneously once daily (hs – 2-12 hours before bedtime) after the initial two-week period.
- Maintenance: Maintain the dose at 250-500 mcg (0.1-0.2 ml or 10-20 units) subcutaneously once daily for ongoing support in sleep regulation and quality improvement.
- Duration: DSIP is administered daily.
- Weeks 1-2: 250 mcg (0.1 ml or 10 units) of DSIP once daily (hs – 2-12 hours before bedtime)
- Week 3 and onwards: 250-500 mcg (0.1-0.2 ml or 10-20 units) of DSIP once daily (hs – 2-12 hours before bedtime)
*Provided as a standard protocol, dose may vary depending on the condition of the patient.
*The dosage of DSIP may be adjusted based on the individual’s response, medical history, and specific treatment goals.
- Restrictions
- Known hypersensitivity to DSIP or any component of the formulation.
- Not recommended for use during pregnancy or breastfeeding unless specifically advised by a healthcare provider.
- Patients with severe psychiatric conditions should consult with their healthcare provider before starting this treatment.
- Avoid using other sleep-inducing medications concurrently without professional advice to prevent potential interactions.
- Requirements
- Regular monitoring of sleep patterns and overall sleep quality to assess the effectiveness of the treatment.
- Periodic assessments to check for any adverse effects and to adjust the treatment as necessary.
- Consultation with a healthcare professional before starting DSIP to ensure it is appropriate for the patient’s health condition.
- Patients should maintain a healthy sleep environment and routine to support the effectiveness of the treatment.
Procedure
- DSIP
Reconstitution
- Draw 2 ml of sterile water for injection into a syringe.
- Inject the sterile water into a vial containing 5 mg of DSIP peptide.
- Gently swirl the vial until the peptide is fully dissolved.
- Administration
- Remove the cap from a tuberculin syringe.
- Draw the reconstituted DSIP solution into the syringe to the required dosage (0.1 ml or 10 units initially, 0.2 ml or 20 units after titration).
- Clean the selected injection site with an alcohol swab.
- Pinch the sanitized skin and insert the needle at a 90-degree angle.
- Administer the injection subcutaneously 2-12 hours before bedtime.
- For next usage
- Store the remaining DSIP solution in the refrigerator at 2-8°C.
- Before the next use, clean the vial top with an alcohol swab.
- Use a new syringe for each administration.
- Ensure to rotate injection sites (abdomen, thigh, or upper arm) to minimize skin irritation.
Clinical Research
Study:
Delta Sleep-Inducing Peptide (DSIP) for Sleep Disorders and Withdrawal Syndromes
Source:
Karger Publishers, Jay Campbell, MDPI
Results:
Delta Sleep-Inducing Peptide (DSIP) is a neuropeptide known for its potential to enhance sleep and manage withdrawal symptoms. DSIP is administered via injection, but research has demonstrated its wide range of benefits, including as a vial peptide for sleep induction and managing withdrawal from addictive substances.
DSIP works by influencing various physiological processes, including the modulation of the endocrine system and the central nervous system. It promotes sleep by inducing slow-wave sleep and regulating circadian rhythms. Additionally, DSIP modulates the activity of neurotransmitters such as serotonin, which play a critical role in sleep and mood regulation.
Clinical Benefits: Sleep Disorders: Clinical trials have demonstrated that DSIP effectively improves sleep quality and duration. In studies involving patients with chronic insomnia, DSIP administration resulted in longer sleep duration and higher sleep quality, with fewer interruptions and no significant daytime sedation. DSIP’s sleep-promoting effects were observed up to six hours after administration, suggesting its potential as a treatment for sleep disorders.
Withdrawal Syndromes: DSIP has shown efficacy in treating withdrawal symptoms associated with alcohol and opioid addiction. In clinical trials, DSIP administration significantly reduced the severity of withdrawal symptoms, including anxiety and physical discomfort, providing rapid relief to patients undergoing detoxification. The treatment was well-tolerated with minimal side effects, such as mild headaches in a few patients.
Karger Publishers, 1984; Jay Campbell, 2023; MDPI, 2021.
Read More: https://karger.com/ene/article/23/5/386/119328/A-Clinical-Trial-with-DSIP, https://www.jaycampbell.com/, https://www.mdpi.com/
Articles
Delta sleep inducing peptide (DSIP): effect on respiration activity in rat brain mitochondria and stress protective potency under experimental hypoxia
Neuromodulatory delta sleep inducing peptide (DSIP) seems to be implicated in the attenuation of stress-induced pathological metabolic disturbances in various animal species and human beings. Mitochondria, as cell organelles, are considered especially sensitive to stress conditions. In this work, the influence of DSIP and Deltaran((R))-a recently developed product based upon DSIP-on processes of oxidative phosphorylation […]
Delta Sleep-Inducing Peptide Recovers Motor Function in SD Rats after Focal Stroke
Mutual effect of the preliminary and therapeutic intranasal treatment of SD rats with DSIP (8 days) on the outcome of focal stroke, induced with intraluminal middle cerebral occlusion (MCAO), was investigated. Materials and Methods: The groups were the following: MCAO + vehicle, MCAO + DSIP, and SHAM-operated. DSIP or vehicle was applied nasally 60 (±15) […]
Doctor's Reviews
Delta Sleep Inducing Peptide A comprehensive guide by a doctor and sleep specialist
This little-known peptide could be the key to your best night’s sleep ever. Learn about the fascinating science behind delta sleep inducing peptide, or DSIP, and how it may unlock deep, restorative slumber. Discover why researchers say Delta sleep inducing peptide could revolutionize natural sleep solutions.
Benefits of DSIP | Learn more about the Peptide DSIP
In this video, Dr. Durst explains how CJC-1295 helps with weight loss!
DSIP peptide for sleep #DSIP #peptide #insomnia #fatigue #brainfog #repair #recovery #neurologicali
DSIP peptide for sleep #DSIP #peptide #insomnia #fatigue #brainfog #repair #recovery #neurologicalissues #health #learnontiktok #doctor #optimalhealth.
